Title:
甲状腺癌の予後のためのバイオマーカー
Document Type and Number:
Japanese Patent JP7007761
Kind Code:
B2
Abstract:
The present disclosure provides a method of prognosis of thyroid cancer including obtaining an exosome from a subject who had received a therapy of thyroid cancer such as thyroidectomy, and detecting whether thyroglobulin is present in the exosome. Moreover, the present disclosure provides the use of urinary exosomal thyroglobulin in being a non-invasive, reproducible, convenient, serial, and accurate follow-up marker for patient with thyroid cancer.
Inventors:
King Jiyuan
Tien Chong
Tien Chong
Application Number:
JP2020537065A
Publication Date:
March 04, 2022
Filing Date:
May 15, 2018
Export Citation:
Assignee:
National Taiwan University
International Classes:
G01N33/68; G01N27/62
Domestic Patent References:
| JP2017062244A | ||||
| JP2016165284A | ||||
| JP8297123A | ||||
| JP2012512389A |
Foreign References:
| US20170146542 |
Attorney, Agent or Firm:
Shinichiro Tanaka
Yoshi Kazuhiko Ta
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Machi Kobayashi
Yoshi Kazuhiko Ta
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Machi Kobayashi